AC Immune Beefs Up Neurodegenerative Diseases Pipeline

The Swiss biotech, AC Immune, has identified further antibodies aimed at targets in neurodegenerative diseases that could complement its work in beta-amyloid and tau-based approaches to conditions like Alzheimer's disease.

A C Immune Art
Antigenic peptides on the surface of liposomes • Source: AC Immune

More from Business

More from Scrip